Molecular Matrix
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3410 Industrial Blvd Ste 103, West Sacra...Phone Number
(916) 376-9404Website
www.molecularmatrix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Molecular Matrix
Molecular Matrix Inc. (MMI) is a biotechnology company that began as a startup at UC Davis, and has successfully developed and commercialized a synthetic hyper-crosslinked carbohydrate polymer (HCCP) for tissue engineering. MMI's synthetic bone graft substitute, Osteo-P® BGS, has been producing favorable clinical outcomes for patients since its launch in 2011. Since October 2020, MMI has been providing reliable COVID-19 RT-PCR testing through its CLIA certified laboratory in West Sacramento.Explore more
Molecular Matrix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Molecular Matrix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Molecular Matrix had a recent Job posting/layoffs
Check out if Molecular Matrix is spiking on competitors!
Product Launch: Get notified when Molecular Matrix launches new products
Congratulate Masked Content for being promoted to Masked Content at Molecular Matrix
Earning: See what the market has to say on Molecular Matrix recently announced quarterly report
Website visits: Recent activity has been detected on your website
Molecular Matrix, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Molecular Matrix has new funding data
Check if Molecular Matrix has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Molecular Matrix
Find 3 more new buyers
Compare Similar Companies to Molecular Matrix
Compare insights from companies similar to Molecular Matrix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Molecular Matrix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Molecular Matrix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Molecular Matrix.
Molecular Matrix financials insights
Gather financial insights about Molecular Matrix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Private Equity
$855K
Molecular Matrix Tech Stack
A closer look at the technologies used by Molecular Matrix
See more technologies
Molecular Matrix News & Media
Molecular Matrix and GenScript Partner to Launch SARS-CoV-2 Neutralizing Antibody Testing Service for Public
PISCATAWAY, New Jersey and WEST SACRAMENTO, Calif., April 13, 2021 /PRNewswire/ -- Molecular Matrix, Inc. (MMI) and GenScript Biotech Corp. announced today that they have partnered to offer GenScript's SARS-CoV-2 neutralizing antibody test to the public via physician screening....Molecular Matrix, Inc. Forms Strategic Alliance with Philosys Healthcare
Molecular Matrix, Inc. is forming a strategic alliance with Philosys Healthcare to expand the availability of a next-generation bone graft substitute technology to the Asian market. (PRWeb September 12, 2019) Read the full story at https://www.prweb.com/releases/molecular_matrix_inc_forms_strategic_alliance_with_philosys_healthcare/prweb16560689.htmMolecular Matrix Adds Steve Whitlock To Management Team
Move enhances product development and commercialization expertise (PRWeb January 30, 2018) Read the full story at http://www.prweb.com/releases/2018/01/prweb15144576.htmMolecular Matrix, Inc. Receives a 510K Clearance for its Revolutionary Bone Graft Substitute Technology, Osteo-P™
Exceptional resorption profile earns FDA nod (PRWeb January 17, 2018) Read the full story at http://www.prweb.com/releases/2018/01/prweb15095110.htm
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Molecular Matrix
Sign Up For FreeTo access detailed company insights
Molecular Matrix Inc. (MMI) is a biotechnology company that began as a startup at UC Davis, and has successfully developed and commercialized a synthetic hyper-crosslinked carbohydrate polymer (HCCP) for tissue engineering. MMI's synthetic bone graft substitute, Osteo-P® BGS, has been producing favorable clinical outcomes for patients since its lau... Read More
